Among them, cytokeratin 18 (CK18) levels are elevated during the apoptosis or necroptosis of hepatocytes in patients with NASH, and CK18 is a well-validated single marker for the diagnosis of NASH9. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatohepatitis.